Company Overview and News

 
Asanko Gold Announces Q1 2018 Production Results

4h globenewswire
VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE American:AKG) announces production results for the first quarter (“Q1”) of 2018 from the Asanko Gold Mine (“AGM”), located in Ghana, West Africa.

 
3 Top Gold Stocks for a Safe Haven After Syria Attacks

2018-04-17 investorplace
Gold prices hit $1,350 per ounce for the 13th time in the last five years in yesterday’s trading, after hovering around the psychological level of $1,300 over the last week.The prime catalyst behind the rally was the military attacks in Syria, spearheaded by the United States and its allies.

 
3 Top Gold Stocks for a Safe Haven After Syria Attacks

2018-04-17 zacks
Gold prices hit $1,350 per ounce for the 13th time in the last five years in yesterday’s trading, after hovering around the psychological level of $1,300 over the last week.The prime catalyst behind the rally was the military attacks in Syria, spearheaded by the United States and its allies. Furthermore, war-related geopolitical risks are lifting up crude oil prices, in turn boosting gold’s value in the market.

1
Golden Star Resources (GSS) in Focus: Stock Moves 6.1% Higher

2018-04-16 zacks
Golden Star Resources Ltd. (GSS - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on Friday. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $0.57 to $0.65 in the past one-month time frame. The move came after the company raised its Inferred Mineral Resources estimate by more than doubled for the Wassa Underground Gold Mine in Ghana.

6
AKG / Asanko Gold Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-04-10 sec.gov
Asanko Gold Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2018 Commission File No. 001-33580

 
Asanko Gold Wins Outstanding Workplace Malaria Control Award 

2018-04-10 globenewswire
VANCOUVER, British Columbia, April 10, 2018 (GLOBE NEWSWIRE) -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE American:AKG) is pleased to announce that the Asanko Gold Mine has won the Outstanding Workplace Malaria Control Award, presented by the Private Sector Malaria Prevention Project (“PSMP”) at John Hopkins Center for Communication, as part of the West Africa Regional Malaria Safe awards.

1
AKG / Asanko Gold Inc. / Gold Fields Ltd - SC 13D (Activist Investment)

2018-04-09 sec.gov
SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

2
AKG / Asanko Gold Inc. / Gold Fields Ltd - SC 13D (Activist Investment)

2018-04-09 sec.gov
SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

 
Portfolio Sizing: A Top Key To Trading Success - Part 2

2018-04-09 seekingalpha
Large losses and irresponsible position sizing are not only damaging to the account, they are extremely damaging to a trader's mental capital.

1
AKG / Asanko Gold Inc. null (Current Report of Foreign Issuer)

2018-04-06 sec.gov
F6K20180405 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2018 Commission File No. 001-33580 ASANKO GOLD INC. (Translation of registrant's n

 
UPDATE 1-Ghana to review corporate tax exemptions for resources sector

2018-04-04 reuters
ACCRA, April 4 (Reuters) - Ghana plans to review its process for granting corporate tax exemptions to mining and oil companies as part of measures to eliminate fraud and boost revenues, its vice president said on Wednesday.

1
Gold Mining Bull: Top News And Month In Review

2018-04-04 seekingalpha
Here's a monthly recap of the top news in the gold mining sector, including drill results, takeover announcements and other relevant updates, to keep readers up-to-date on news in the sector. Here's my update for February if you missed it.

 
PVH Corp. (PVH) Soars: Stock Adds 5.2% in Session

2018-04-02 zacks
PVH Corp.(PVH - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $139.86 –$145.25 in the past one-month time frame, witnessed a sharp increase on Thursday.

 
Surging Earnings Estimates Signal Good News for KLX (KLXI)

2018-04-02 zacks
KLX Inc. (KLXI - Free Report) is a distributor and service provider of aerospace fasteners and consumables that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well. These positive earnings estimate revisions suggest that analysts are becoming more optimistic on KLXI’s earnings for the coming quarter and year.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 04341Y105